THE Food and Drug Administration (FDA) has warned the public against the presence of four unregistered drug products in the market. In its Advisory 2024-1312 on ...
Over the next three months, the agency could approve a rival to a fast-selling Pfizer heart drug, a much-debated lung cancer medicine and an addition to Vertex's dominant cystic fibrosis business.